Evaluation of the effect of Memantine and Escitalopram combination on Severity of Symptoms and Cognitive Function Among Patients with Obsessive-Compulsive Disorder
Phase 4
Recruiting
- Conditions
- Obsessive-Compulsive Disorder.K12.0
- Registration Number
- IRCT20191106045356N11
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Diagnosis of OCD based on DSM-5 by a psychiatrist
Patients with a Y-BOCS= score of 21
Patients 18 to 60 years
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Obsession score. Timepoint: Before and after treatment. Method of measurement: Examination of the patient and based on a standard questionnaire.
- Secondary Outcome Measures
Name Time Method Obsession, stress, and anxiety. Timepoint: Before and after treatment. Method of measurement: DASS-21.